Senior Associate Scientist



201-500 employees

Develops and commercializes cell and gene therapies

Industrial & Manufacturing


Waltham, MA, USA

  • Bachelor or Master of Science (MS preferred) in Biology, Immunology, Molecular Biology or Biochemistry, with 5+ years of hands-on experience in the development of new biological therapeutics or pharmaceutical products is required
  • Direct experience with flow cytometry, and cell-based assay characterization is a requirement.
  • Experience with primary human B cell culture and techniques to transduce and characterize primary B cells is a plus.
  • Experience in CRISPR-based engineering of human cells is preferred.
  • Detail-oriented, organized, and technically skilled.
  • Highly adaptable and responsive, and committed to completing tasks in a timely fashion
  • Demonstrated ability to work in a dynamic environment as a team player with a strong work ethic
  • Excellent team player with good interpersonal and communication skills
  • Able to maintain written records in the form of laboratory notebooks (paper or electronic)
  • Excellent oral and written communication skills
  • Employ CRISPR editing technology for the genetic modification of human B cells.
  • Develop and conduct in vitro analytical and functional bioassays for characterizing engineered B cells.
  • Assist in the expansion and cell banking of engineered cell lines, laboratory maintenance, generation of SOPs and other technical documents as needed.

ElevateBio stands out as a leader in the cell and gene therapy industry, with its unique integration of diverse technology platforms such as gene editing and cellular engineering, and its state-of-the-art facilities. The company's BaseCamp manufacturing platform offers process innovation and cGMP manufacturing capabilities, enabling the production of viral vectors, RNA, and cell therapies. With a team of industry-leading experts and a commitment to accelerating the development of transformative therapies, ElevateBio is not only expanding its collaborations with industry partners but also actively developing its own portfolio of cellular and genetic medicines.

Company Stage

Series D

Total Funding



Waltham, Massachusetts



Growth & Insights

6 month growth


1 year growth


2 year growth